Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A randomized, placebo-controlled trial

Research output: Contribution to journalArticlepeer-review

134 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A randomized, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences